PROTOTYPE DESIGN OF LYMPHOCYTE TCD4+ RESISTANT AGAINST HIV INFECTION GENERATED FROM PERIPHERAL BLOOD HAEMATOPOIETIC STEM CELL (PBMCs) By DELETION OF 32 bp CCR5 ENCODING GENE

Purwati Purwati

= http://dx.doi.org/10.20473/jscrte.v1i1.7566
Abstract views = 106 times | views = 105 times

Abstract


AIDS epidemic has spread to all parts of Indonesia and currently more than 150 countries reported the existence of HIV/AIDS from around the world. Additionally, HIV/AIDS treatment using ARV drugs also find obstacles that must be faced in terms of host, environment and the agent. The objective of this study was to generate lymphocytes TCD4+ that are resistant to HIV infection generate from PBMCs through by deletion of 32 bp CCR5 encoding gene. In principle, this study was done in three steps. First, isolation, culture and purification of lymphocyte TCD4+ from PBMC (Mather, 2008; Rantam, et.al., 2009). Second, lymphocyte TCD4+ characterization by PCR with primer F 5’CAAGTCGAGCGCCCCGCAAGGGG-3, R 5’GTCCGAGTGTGGCTGATCATCC-3 (Thomsen, et.al., 2002; Yuwono, 2006; Hall and Ziedonis 2007; Purwati, et.al., 2009). Third, designing of lymphocyte TCD4+ prototype which was resistant to HIV infection by deletion of 32 bp CCR5 full gene. Results: Twenty-four hours after culture, there were abundant cell growths. TCD4+ lymphocytes from isolated and cultured 10 ml PBMC were found to be 2 x 107. Phenotype characterization of TCD4+ lymphocyte provided positive results, while the genotype showed similarities to that in corresponding gene bank of CCR5 variant A and variant B. Prototype of HIV resistant TCD4+ lymphocytes was made by nucleotide deletions in conserved areas, at position 554-576 bp, using restriction enzymes EcoRI checked using PCR and sequencing. In conclusion, prototype design of HIV resitent TCD4+ lymphocytes is obtained through the deletion of 32 bp CCR5 encoding full gene at GTCAGTATCAATTCTGGAA GAATTT CCAGACA using EcoRI enzyme.

Keywords: HIV/AIDS, resistant TCD4+ lymphocytes, mutant 32 bp CCR5, PBMCs, deletion

Keywords


HIV/AIDS, resistant TCD4+ lymphocytes, mutant 32 bp CCR5, PBMCs, deletion, stem cell, education, science

References


Anderson, J., Akkina, R. 2007. ‘Complete Knockdown of CCR5 by lentiviral vector-expressed RNAs and protection of transgenic macrophages against HIV-1 infection’. Gene Therapy, Vol. 14, No. 14, pp. 1287–1297.

Blau, H.M., Pavlath, G. K., Hardeman, E. C., et al. 1985. ‘Plasticity of the differentiated state’. Science, Vol. 230, pp. 758–766.

Cakraborty, R. and Jones, R. S. 1999. ‘The Pathogenesis of HIV Disease’. J HIV Ther, Vol. 4, pp. 2-8.

CDC. 2009. Centers for Disease Control and Prevention. 1600 Clifton Rd, Atlanta, GA 30333, USA.

Depkes. 2006. ‘Situasi Epidemi HIV/AIDS di Indonesia’. In: Situasi Perilaku Berisiko dan Prevalensi HIV di tanah Papua. Komisi Penanggulangan AIDS. Jakarta, pp. 1-3.

Depkes. 2009. ‘Perkembangan Kasus AIDS 2000-2009’. In: Situasi HIV & AIDS di Indonesia. Komisi Penanggulangan AIDS. Jakarta, pp. 1-6.

Essex, M., Kanki, P. J. 1989. ‘The Origins of the AIDS virus. The Science of AIDS’. In: WH Freeman. New York, pp. 27-37.

Hall, B. H., and Ziedonis, R.H. 2007. ‘An Empirical Analysis of Patent Litigation in the Semiconductor Industry’. In: Preliminary version prepared for the 2007 American Economic Association annual meeting. Chicago, IL.

Hammer, S. M. 2005. ‘Clinical Practice. Management of Newly diagnosed HIV infection’. N Engl J Med. Vol. 353, pp. 1702-10.

Hütter, G., Daniel, M.D., Maximilian, Mossner, B.S., et.al. 2009. ‘Long-Term Control of HIV by CCR5 Delta32/Delta32 Stem-Cell Transplantation’. J New England Med. Vol. 360, pp. 692-698.

Jackson, K. A., Mi, T., Goodell, M. A. 1999. ‘Hematopoietic potential of stem cells isolated from murine skeletal muscle’. ProcNatlAcadSci. Vol. 14, pp. 482–486.

Leung, W.C., Mak, D., Wong, K.H., Wang ,Y.H., Song, D.N., Wong, C., Shao, Y.M., Lim, W.L. 2008. ‘Molecular Epidemiology Demonstrated Three Emerging Clusters of Human Immunodeficiency Virus Type 1 Subtype B Infection in Hong Kong’. Aids Research And Human Retroviruses, Vol. 24, p. 7.

Liu, R., Paxton, W. A., Choe, S. 1996. ‘Homozygousdefect in HIV-1 coreceptor accounts for resistance of some multiply-exposedindividuals to HIV-1 infection’. Cell, Vol. 86, pp. 367–377.

Pardis, C., Sabeti, Emily, W., Steve, F., Schaffner, Patrick, V., Ben, F., Holli, B., Hutcheson, Mike, C., Tarjei, S. M., Jessica, R., Nick, P., Richard, C., David, R., David,A., Stephen, O., Eric, S. L. 2005. ‘The case for selection at CCR5-Delta32’. PLoS Biology, Vol. 3, No. 11, p. e378.

Purwati, Rantam, F. A., Nasronudin. 2010. ‘Kinetic of HIV infection on Limphocyte Stem Cell Based on Focus Forming Unit (FFU)’. In: Dutch Fondation Symposium 2010.

Purwati, Rantam, F. A., Nasronudin. 2010. ‘Promising Hematopoetic Stem Cell for Treatment in Immunocompremized Condition: Focus on HIV/AIDS’. In: Konas PETRI Bali 2010.

Rantam, F. A., Ferdiansyah, Nasronudin, Purwati. 2009. Stem Cells and Exploration. Airlangga University Press, Surabaya.

Rantam, F. A., Ferdiansyah, Purwati, Nasronudin. 2010. Protokol Isolasi dan Kultur Sel Punca Hematopoetik. Airlangga University Press, Surabaya.

Riyadi, W. 2010. Parameter Penting Desain Primer. Accessed on Oct. 15, 2010. http://sciencebiotech.net/parameter_penting_desain_primer.

Rizzardi, G. P. and Pantaleo, G. 2000. ‘The Immunopathogenesis of HIV-1 Infection’. In: Infectious Diseases. London: Mosby Co. p. 61-12.

Samson, M., Libert, F., Doranz, B. J., et al. 1996. ‘Resistanceto HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5chemokine receptor gene’. Nature. Vol. 382, pp. 722–725.

Thomsen, R., Gary B., Fogel, T., Krink, H. 2002. ‘A Clustal Alignment Improver using Evolutionary Algorithms’. IEEE.

Widiyatna. 2009. ‘Mencermati prevalensi HIV/AIDS’. In: Komunikasi on Line 16 September 2009.

Yuwono, T. 2006. Teori dan Aplikasi Polymerase Chain Reaction. ANDI. Yogyakarta.


Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Journal of Stem Cell Research and Tissue Engineering

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.